Assignee
CEMPRA PHARMACEUTICALS INC
US·8 granted patents·17 pending applications·14 citations·filing 2011–2018
Top patents by PatentIndex Score
25 records- 0191US8759500B2Crystalline forms of a macrolide, and uses thereforCEMPRA PHARMACEUTICALS INC·Filed 2013·Granted Jun 24, 2014·12 cites·23 claims
- 0274US9901592B2Methods for treating resistant diseases using triazole containing macrolidesCEMPRA PHARMACEUTICALS INC·Filed 2014·Granted Feb 27, 2018·1 cites·27 claims
- 0372US9669046B2Biodefenses using triazole-containing macrolidesCEMPRA PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·1 cites·20 claims
- 0465US9439918B2Methods for treating gastrointestinal diseasesCEMPRA PHARMACEUTICALS INC·Filed 2014·Granted Sep 13, 2016·0 cites·24 claims
- 0564US2018369262A1Methods for treating resistant diseases using triazole containing macrolidesCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0660US9751908B2Convergent processes for preparing macrolide antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2014·Granted Sep 5, 2017·0 cites·17 claims
- 0760US2019209530A1Powder oral suspension formulations of antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0859US2019048035A1Processes for preparing macrolides and ketolides and intermediates thereforCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0959US2019023731A1Convergent processes for preparing macrolide antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1059US2019040096A1Crystalline forms of a macrolide, and uses thereforCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1157US2019038653A1Compounds and methods for treating inflammatory diseasesCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1254US2019054059A1Parenteral formulations of macrolide antibioticsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1353US2019241602A1Process for the preparation of macrolide antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1452US2016244472A1Crystalline forms of a macrolide, and uses thereforCEMPRA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1551US2015232500A1Processes for preparing macrolides and ketolides and intermediates thereforCEMPRA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1651US2017224664A1Powder oral suspension formulations of antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1750US2013045937A1Parenteral formulations of macrolide antibioticsCEMPRA PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 1849US10131684B2Process for the preparation of macrolide antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2016·Granted Nov 20, 2018·0 cites·26 claims
- 1946US10188674B2Parenteral formulations for administering macrolide antibioticsCEMPRA PHARMACEUTICALS INC·Filed 2013·Granted Jan 29, 2019·0 cites·28 claims
- 2046US2021137961A1Compositions and Methods for Treating Dry Eye DiseasesCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2145US9861616B2Methods for treating respiratory diseases and formulations thereforCEMPRA PHARMACEUTICALS INC·Filed 2014·Granted Jan 9, 2018·0 cites·27 claims
- 2245US2019328759A1Parenteral formulations for administering macrolide antibioticsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2342US2018044365A1Processes for preparing fluoroketolidesCEMPRA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2436US2018016226A14-azidobutylamines and processes for preparingCEMPRA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2532US2017165286A1Compositions and methods for treating diabetes and liver diseasesCEMPRA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CEMPRA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →